Rapid diagnostic testing, repurposing drug therapies and vaccines targeting innate immunity, are integral factors in mitigating COVID-19

The Global Virus Network (GVN), a coalition of the world’s leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from across the globe to discuss key takeaways from the GVN virtual 2020 Special Annual Meeting held September 23-24, 2020. “We do not know what the future holds for COVID-19 – there may be seasonal variations or chronic infections or maybe a slowdown,” said Dr. Christian Bréchot, GVN President. “However, we know that we have to prepare and that this for now and not after the end of this pandemics; in the spirit of preparation, it is very timely that we used the Special Annual Meeting to band together international experts to identify and analyze what went wrong, what has been properly handled and what recommendations we can confidently make.” Key findings during the meeting regarding SARS-CoV-2 and COVID-19 research...